Noramco and SPI Pharma sign agreement to develop ready-to-implement, patient-friendly formulations…
Noramco and SPI Pharma have signed an agreement to develop and license a set of “value-added” formulation packages for global pharmaceutical manufacturers of finished dosage forms.…
Read More...
Read More...
